行情

PSTI

PSTI

Pluristem疗法
NASDAQ

实时行情|Nasdaq Last Sale

1.680
-0.020
-1.18%
盘后: 1.690 +0.01 +0.60% 19:59 01/21 EST
开盘
1.660
昨收
1.700
最高
1.740
最低
1.660
成交量
63.12万
成交额
--
52周最高
8.60
52周最低
1.360
市值
5,392.74万
市盈率(TTM)
-0.9395
分时
5日
1月
3月
1年
5年
15 Worst Stock Picks of Cathie Wood
In this article, we discuss the 15 worst stock picks of Cathie Wood. If you want to skip our detailed analysis of these stocks, go directly to the 5 Worst Stock Picks of Cathie Wood. Cathie Wood, the chief ARK Investment Management, is often hailed as the ...
Insider Monkey · 1天前
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device Designation for the treatment of chronic chemo induced peripheral neuropathy with its wearable neurostimulation technology.
Benzinga · 4天前
NeuroMetrix, Mainz lead healthcare gainers; Dyne, Allarity among losers
Gainers: NeuroMetrix (NASDAQ:NURO) +39%. Mainz Biomed MYNZ +26%. Immuron (NASDAQ:IMRN) +22%. . Cardiol Therapeutics CRDL +15%. Pluristem Therapeutics PSTI +13%. Losers: Dyne Therapeutics DYN -17%. Allarity Therapeutics (NASDAQ:ALLR) -15%. Molecular Partner...
Seekingalpha · 4天前
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 4天前
PSTI, NES and VORB among mid-day movers
Gainers: Splash Beverage Group (NYSE:SBEV) +37%. Virgin Orbit Holdings (NASDAQ:VORB) +26%. TSR (NASDAQ:TSRI) +27%. Accolade (NASDAQ:ACCD) +26%. BARK (NYSE:BARK) +25%. Veru (NASDAQ:VERU) +22%. Nutriband (NASDAQ:NTRB) +22%. Nuverra Environmental Solutions (N...
Seekingalpha · 01/11 17:39
昨天的 60 大推动者
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.
Benzinga · 01/11 09:52
MRIN, NRIX and ELYM among mid-day movers
Gainers: Bone Biologics (OTCPK:BBLG) +82%. Zynga (NASDAQ:ZNGA) +43%. RxSight (NASDAQ:RXST) +34%. Olink (NASDAQ:OLK) +31%. Apria (NASDAQ:APR) +26%. Molecular (NASDAQ:MOLN) +25%. iRhythm Technologies (NASDAQ:IRTC) +25%. BioCryst (NASDAQ:BCRX) +21%. G Medical...
Seekingalpha · 01/10 17:44
45 Stocks Moving In Monday's Mid-Day Session
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
Benzinga · 01/10 17:14
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解PSTI最新的财务预测,通过PSTI每股收益,每股净资产,每股现金流等数据分析Pluristem疗法近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

25.00%强力推荐
50.00%买入
25.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测PSTI价格均价为7.88,最高价位10.00,最低价为3.000。
最高10.00
均价7.88
最低3.000
现价1.680
EPS
实际EPS
预期EPS
-0.39-0.29-0.20-0.10
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 78
机构持股: 452.31万
持股比例: 14.09%
总股本: 3,209.96万
类型机构数股数
增持
20
69.61万
建仓
3
6.85万
减持
16
66.95万
平仓
8
23.15万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.82%
制药与医学研究
-1.11%
高管信息
Chairman/Executive Director
Zalman Aberman
President/Chief Executive Officer/Director
Yaky Yanay
Chief Financial Officer/Treasurer/Secretary
Chen Franco-Yehuda
Director
Rami Levi
Director
Varda Shalev
Independent Director
Doron Birger
Independent Director
Mark Germain
Independent Director
Moria Kwiat
Independent Director
Maital Shemesh-Rasmussen
Independent Director
Doron Shorrer
暂无数据
PSTI 简况
Pluristem Therapeutics Inc.是一家开发治疗多发性缺血、炎症和血液病症的胎盘细胞治疗候选产品的开发商。该公司的主要适应症是重症肢体缺血(CLI)、术后股骨颈骨折恢复和急性放射综合征。该公司主要从事细胞治疗与相关技术的研究、开发、临床试验和制造业务。该公司的产品包括PLX-PAD和PLX R18。该公司的PLX细胞是使用三维(3D)过程扩展的贴壁基质细胞(ASC)。该公司的系统利用合成支架创造胎盘基质细胞可以生长的人造3D环境。该公司的PLX产品使用标准针头和注射器进行给药。该公司的PLX产品正处于多种适应症的临床开发阶段,如心血管、骨科、肺部与妇女健康等疾病。

微牛提供Pluristem Therapeutics Inc.(NASDAQ-PSTI)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的PSTI股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易PSTI股票基本功能。